Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Schizophrenia is a devastating neurodevelopmental disorder whose genetic influences remain elusive. We hypothesize that individually rare structural variants contribute to the illness. Microdeletions and microduplications >100 kilobases were identified by microarray comparative genomic hybridization of genomic DNA from 150 individuals with schizophrenia and 268 ancestry-matched controls. All variants were validated by high-resolution platforms. Novel deletions and duplications of genes were present in 5% of controls versus 15% of cases and 20% of young-onset cases, both highly significant differences. The association was independently replicated in patients with childhood-onset schizophrenia as compared with their parents. Mutations in cases disrupted genes disproportionately from signaling networks controlling neurodevelopment, including neuregulin and glutamate pathways. These results suggest that multiple, individually rare mutations altering genes in neurodevelopmental pathways contribute to schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, a rare CNV for ERBB4 has been identified in schizophrenia46.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [46]
In the citing paper
“In addition, rare but highly penetrant CNVs have been found in many genes encoding synaptic proteins46.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [46]
In the citing paper
“Early findings from our group observed a 3-fold enrichment of rare genic CNVs in cases as compared with controls (Walsh et al., 2008).”
From CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics (2012) · cites this paper as Walsh et al., 2008
In the citing paper
“Early on, it was apparent that rare CNVs tended to impact genes involved in neuronal function (Walsh et al., 2008). These included functional categories related to synaptic activity and neurodevelopment (Malhotra et al., 2011; Walsh et al., 2008).”
From CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics (2012) · cites this paper as Walsh et al., 2008
In the citing paper
“While the strength of evidence supporting specific pathways differs between data sets, we do find evidence consistent with our earlier observations that there is an enrichment of “neurodevelopmental” and “synaptic” genes among rare CNVs in SCZ (Walsh et al., 2008).”
From High frequencies of de novo CNVs in bipolar disorder and schizophrenia (2011) · cites this paper as Walsh et al., 2008
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Detection of large-scale variation in the human genome
Iafrate, A. J., Feuk, L., Rivera, M. N., Listewnik, M. L., Donahoe, P. K., Qi, Y., Scherer, S. W., & Lee, C. (2004) · Nature Genetics · doi:10.1038/ng1416 · Cited by 2,892
Strong association of de novo copy number mutations with autism
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007) · Science · doi:10.1126/science.1138659 · Cited by 2,795
Self-citationSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
Association between Microdeletion and Microduplication at 16p11.2 and Autism
Weiss, L. A., Shen, Y., Korn, J. M., Arking, D. E., Miller, D. T., Fossdal, R., Saemundsen, E., Stefansson, H., Ferreira, M. A. R., Green, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa075974 · Cited by 1,666
Mapping autism risk loci using genetic linkage and chromosomal rearrangements
The Autism Genome Project Consortium (2007) · Nature Genetics · doi:10.1038/ng1985 · Cited by 1,402
Segmental Duplications and Copy-Number Variation in the Human Genome
Sharp, A. J., Locke, D. P., McGrath, S. D., Cheng, Z., Bailey, J. A., Vallente, R. U., Pertz, L. M., Clark, R. A., Schwartz, S., Segraves, R., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/431652 · Cited by 972
Self-citationRecurrent 16p11.2 microdeletions in autism
Kumar, R. A., KaraMohamed, S., Sudi, J., Conrad, D. F., Brune, C., Badner, J. A., Gilliam, T. C., Nowak, N. J., Cook, E. H., Dobyns, W. B., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm376 · Cited by 731
Genomic Disorders: Molecular Mechanisms for Rearrangements and Conveyed Phenotypes
Lupski, J. R., & Stankiewicz, P. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010049 · Cited by 582
The DISC locus in psychiatric illness
Chubb, J. E., Bradshaw, N. J., Soares, D. C., Porteous, D. J., & Millar, J. K. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002106 · Cited by 542
Research works printed but not linked: 4
- G. Kirovet al., Hum. Mol. Genet.17, 458 (2008).
- National Center for Biotechnology Information National Library of Medicine Bethesda MD www.ncbi.nlm.nih.gov.
- K. M. Giehl, Prog. Exp. Tumor Res.39, 1 (2007).
- N. Nortonet al., Am. J. Med. Genet. B Neuropsychiatr. Genet.141, 96 (2006).
Cited by
Items 301–400 of 1,001
The discovery of human genetic variations and their use as disease markers: past, present and future
Ku, C., Loy, E. Y., Salim, A., Pawitan, Y., & Chia, K. S. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.55 · Cited by 137
Genomics and Genetics in the Biology of Adaptation to Exercise
Bouchard, C., Rankinen, T., & Timmons, J. A. (2011) · Comprehensive Physiology · doi:10.1002/cphy.c100059 · Cited by 136
“So far, CNVs have been reported to be associated with developmental and neuropsychiatric disorders (188, 199, 366), while their contribution to more common diseases is still unclear (66).”
Wöhr, M., Silverman, J. L., Scattoni, M. L., Turner, S. M., Harris, M. J., Saxena, R., & Crawley, J. N. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.024 · Cited by 115
“Genetic alterations in NRXN1 are associated with the occurrence of schizophrenia in humans [25,26,32-37,39].”
BackgroundCompton, M. T., & Walker, E. F. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn151 · Cited by 136
“In fact, recent evidence from a genomic DNA scan of patients and controls indicates that this is indeed the case for patients with schizophrenia.(71) That study revealed significantly more microdeletions and microduplications in patients compared with healthy controls, including the biological relatives of the patient…”
BackgroundResultMyelin, myelin-related disorders, and psychosis
Mighdoll, M. I., Tao, R., Kleinman, J. E., & Hyde, T. M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.09.040 · Cited by 135
“Many of these genes play an important role in brain development (Weinberger, 1986; Walsh et al., 2008).”
BackgroundLee, K. W., Woon, P. S., Teo, Y. Y., & Sim, K. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.09.001 · Cited by 135
Suggestion of Roles for Both Common and Rare Risk Variants in Genome-wide Studies of Schizophrenia
Owen, M. J., Craddock, N. J., & O’Donovan, M. C. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.69 · Cited by 134
Prepulse Inhibition of the Startle Reflex: A Window on the Brain in Schizophrenia
BRAFF, D. L. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_61 · Cited by 134
Unravelling the genetic basis of schizophrenia and bipolar disorder with GWAS: A systematic review
Prata, D. P., Costa-Neves, B., Cosme, G., & Vassos, E. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.04.007 · Cited by 133
Bauer, D., Haroutunian, V., Meador-Woodruff, J. H., & McCullumsmith, R. E. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.07.025 · Cited by 124
Mefford, H. C., Cooper, G. M., Zerr, T., Smith, J. D., Baker, C., Shafer, N., Thorland, E. C., Skinner, C., Schwartz, C. E., Nickerson, D. A., et al. (2009) · Genome Research · doi:10.1101/gr.094987.109 · Cited by 132
“This is particularly true for neurocognitive disorders like intellectual disability (ID), autism, and schizophrenia (Christian et al. 2008; de Vries et al. 2005; Friedman et al. 2006; International Schizophrenia Consortium 2008; Kirov et al. 2009; Kumar et al. 2008; Marshall et al. 2008; Rosenberg et al. 2006; Sebat e…”
BackgroundSelf-citationHuman genetics and genomics a decade after the release of the draft sequence of the human genome
Naidoo, N., Pawitan, Y., Soong, R., Cooper, D. N., & Ku, C. (2011) · Human Genomics · doi:10.1186/1479-7364-5-6-577 · Cited by 132
“The studies on schizophrenia found that rare structural variations that disrupt multiple genes in neurodevelopmental pathways are over-represented in cases, as compared with controls.(250,289)”
ResultRaychaudhuri, S., Korn, J. M., McCarroll, S. A., The International Schizophrenia Consortium, Altshuler, D., Sklar, P., Purcell, S., & Daly, M. J. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001097 · Cited by 131
The FMRP regulon: from targets to disease convergence
Fernández, E., Rajan, N., & Bagni, C. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00191 · Cited by 111
“…et al., 2012), the tyrosine kinase or BDNF/NT-3 growth factor (TrkB) receptors (Napoli et al., 2008; Louhivuori et al., 2011; De Rubeis et al., 2013), the dopamine (DA) receptors (Wang et al., 2008) and recently the cannabinoid receptors (Maccarrone et al., 2010; Busquets-Garcia et al., 2013).”
BackgroundSchmidt‐Kastner, R., van Os, J., Esquivel, G., Steinbusch, H. W. M., & Rutten, B. P. F. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.183 · Cited by 131
Emerging themes and new challenges in defining the role of structural variation in human disease
Sharp, A. J. (2009) · Human Mutation · doi:10.1002/humu.20843 · Cited by 125
“However, given recent data that suggest a disease model in which multiple rare CNVs contribute to a variety of human phenotypes [Sebat et al., 2007; Walsh et al., 2008], concerted efforts in this area hold the promise to reveal the genetic factors underlying many human diseases.”
Scott, A. J., Chiang, C., & Hall, I. M. (2021) · Genome Research · doi:10.1101/gr.275488.121 · Cited by 134
“…also been implicated in the biology of human diseases such as autism spectrum disorder (Brandler et al. 2018; Sebat et al. 2007; Turner et al. 2017; Weiss et al. 2008) and schizophrenia (International Schizophrenia Consortium 2008; Marshall et al. 2017; McCarthy et al. 2009; Walsh et al. 2008).”
BackgroundA glimmer of light for neuropsychiatric disorders
Hyman, S. E. (2008) · Nature · doi:10.1038/nature07454 · Cited by 130
“, can result either from multiple common variants or from rare, highly penetrant mutations, it now seems that both schizophreni”
BackgroundSNAP‐25 in Neuropsychiatric Disorders
Corradini, I., Verderio, C., Sala, M., Wilson, M. C., & Matteoli, M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03995.x · Cited by 128
Genome-Wide Study of Structural Variants in Bovine Holstein, Montbéliarde and Normande Dairy Breeds
Boussaha, M., Esquerré, D., Barbieri, J., Djari, A., Pinton, A., Letaïef, R., Salin, G., Escudié, F., Roulet, A., Fritz, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135931 · Cited by 128
Hochstenbach, R., Buizer‐Voskamp, J. E., Vorstman, J. A. S., & Ophoff, R. A. (2011) · Cytogenetic and Genome Research · doi:10.1159/000332928 · Cited by 128
Nithianantharajah, J., McKechanie, A. G., Stewart, T., Johnstone, M., Blackwood, D., Clair, D. S., Grant, S. G. N., Bussey, T. J., & Saksida, L. M. (2015) · Scientific Reports · doi:10.1038/srep14613 · Cited by 128
Toward developmental models of psychiatric disorders in zebrafish
Norton, W. H. J. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00079 · Cited by 127
“GWAS are based upon the principle that multiple disease-causing variants (such as single nucleotide polymorphisms, SNPs) will be maintained in linkage-disequilibrium and so can be detected in an unbiased manner (Frazer et al., 2009).”
BackgroundSZDB: A Database for Schizophrenia Genetic Research
Wu, Y., Yao, Y., & Luo, X. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw102 · Cited by 127
Thalamic Reticular Dysfunction as a Circuit Endophenotype in Neurodevelopmental Disorders
Krol, A., Wimmer, R. D., Halassa, M. M., & Feng, G. (2018) · Neuron · doi:10.1016/j.neuron.2018.03.021 · Cited by 121
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript deletions in SCZ (Walsh et al., 2008) and ASD (Pinto et al., 2010; Prasad et al., 2012).”
Neurexins and neuropsychiatric disorders
Kasem, E. A., Kurihara, T., & Tabuchi, K. (2017) · Neuroscience Research · doi:10.1016/j.neures.2017.10.012 · Cited by 126
The Conflict Between Complex Systems and Reductionism
Heng, H. H. (2008) · JAMA · doi:10.1001/jama.300.13.1580 · Cited by 125
Williams, R., Lim, J. E., Harr, B., Wing, C., Walters, R., Distler, M. G., Teschke, M., Wu, C., Wiltshire, T., Su, A. I., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004649 · Cited by 114
“Data implicating CNV in both autism [24] and schizophrenia [ 25 ] have focused on de novo mutations rather than common CNV alleles.”
InfluentialCopy number variation influences gene expression and metabolic traits in mice
Orozco, L. D., Cokus, S. J., Ghazalpour, A., Ingram-Drake, L. A., Wang, S. S.-M., van Nas, A., Che, N., Araujo, J. A., Pellegrini, M. A., & Lusis, A. J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp360 · Cited by 124
“Recent studies have shown that both inherited and de novo CNVs are associated with autism (11,32,33) and schizophrenia (34,35) in humans, suggesting that CNVs may play a role in the etiology of complex traits.”
BackgroundThe Genetic Architecture of Schizophrenia: New Mutations and Emerging Paradigms
Rodriguez-Murillo, L., Gogos, J. A., & Karayiorgou, M. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-072010-091100 · Cited by 113
Investigation of NRXN1 deletions: Clinical and molecular characterization
Dabell, M. P., Rosenfeld, J. A., Bader, P., Escobar, L. F., El‐Khechen, D., Vallee, S. E., Dinulos, M. B. P., Curry, C., Fisher, J., Tervo, R., et al. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35780 · Cited by 108
Goldmuntz, E., Paluru, P., Glessner, J., Hakonarson, H., Biegel, J. A., White, P. S., Gai, X., & Shaikh, T. H. (2011) · Congenital Heart Disease · doi:10.1111/j.1747-0803.2011.00582.x · Cited by 106
The Major Histocompatibility Complex (MHC) in Schizophrenia: A Review
Mokhtari, R., & Lachman, H. M. (2016) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000479 · Cited by 110
The role of neurexins in schizophrenia and autistic spectrum disorder
Reichelt, A. C., Rodgers, R. J., & Clapcote, S. J. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.024 · Cited by 121
Zhou, B., Ho, S. S., Zhang, X., Pattni, R., Haraksingh, R., & Urban, A. E. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2018-105272 · Cited by 122
Effect of Copy Number Variants on Outcomes for Infants With Single Ventricle Heart Defects
Carey, A. S., Liang, L., Edwards, J., Brandt, T., Mei, H., Sharp, A. J., Hsu, D. T., Newburger, J. W., Ohye, R. G., Chung, W. K., et al. (2013) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.113.000189 · Cited by 114
Cortical Oscillations in Health and Disease
Traub, M., & Whittington, P. (2010) · doi:10.1093/acprof:oso/9780195342796.001.0001 · Cited by 107
The genomics of schizophrenia: update and implications
Giusti-Rodríguez, P., & Sullivan, P. F. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66031 · Cited by 96
“Multiple rare CNVs are now established risk factors for psychiatric disorders, including schizophrenia, mental retardation, and autism (22, 29–33).”
Genetic Basis of Intellectual Disability
Ellison, J. W., Rosenfeld, J. A., & Shaffer, L. G. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-042711-140053 · Cited by 103
Mittal, V. A., & Wakschlag, L. S. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.12.011 · Cited by 112
“Further, approaches that weigh in developmental markers as units of analysis (e.g., mutations disrupting genes from signaling networks controlling neurodevelopment; Walsh et al., 2008) continue to yield important clues about pathophysiology and treatment targets.”
BackgroundSpatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders
Li, J., Zhang, W., Yang, H., Howrigan, D. P., Wilkinson, B., Souaiaia, T., Evgrafov, O. V., Genovese, G., Clementel, V. A., Tudor, J. C., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4594 · Cited by 119
The 3q29 deletion confers >40-fold increase in risk for schizophrenia
Mullé, J. G. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.76 · Cited by 121
Neurodevelopmental and neuropsychiatric behaviour defects arise from 14-3-3ζ deficiency
Cheah, P.-S., Ramshaw, H. S., Thomas, P. Q., Toyo-oka, K., Xu, X., Martin, S., Coyle, P., Guthridge, M. A., Stomski, F., van den Buuse, M., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.158 · Cited by 106
Losing your inhibition: Linking cortical GABAergic interneurons to schizophrenia
Inan, M., Petros, T. J., & Anderson, S. A. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.11.013 · Cited by 101
Berman, R. A., Gotts, S. J., McAdams, H. M., Greenstein, D. K., Lalonde, F. M., CLASEN, L. S., Watsky, R. E., Shora, L., Ordóñez, A. E., Raznahan, A., et al. (2015) · Brain · doi:10.1093/brain/awv306 · Cited by 119
“Given that genetic abnormalities appear to be more salient in this cohort (Walsh et al., 2008; Addington and Rapoport, 2009; Ahn et al., 2014a, b), we anticipate that functional brain phenotypes may also be distinctive.”
BackgroundSelf-citationRisk of psychiatric illness from advanced paternal age is not predominantly from de novo mutations
Gratten, J., Wray, N. R., Peyrot, W. J., McGrath, J. J., Visscher, P. M., & Goddard, M. E. (2016) · Nature Genetics · doi:10.1038/ng.3577 · Cited by 118
Copy Number Variation in Schizophrenia in the Japanese Population
Ikeda, M., Aleksić, B., Kirov, G., Kinoshita, Y., Yamanouchi, Y., Kitajima, T., Kawashima, K., Okochi, T., Kishi, T., Zaharieva, I. T., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.034 · Cited by 118
Bauer, D., Gupta, D., Harotunian, V., Meador-Woodruff, J. H., & McCullumsmith, R. E. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.06.012 · Cited by 111
“…(flu), Trifluoperazine (tri), Prochlorperazine (pro), Thiothixene and Western blot analysis cohorts. a high-risk for schizophrenia allele of the GRM3 metabotropic glutamate receptor is associated with decreased EAAT2mRNA expression in human prefrontal cortex (Egan et al., 2004; Walsh et al., 2008).”
Walsh, T., Pierce, S. B., Lenz, D. R., Brownstein, Z., Dagan‐Rosenfeld, O., Shahin, H., Roeb, W., McCarthy, S., Nord, A. S., Gordon, C. R., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.05.011 · Cited by 118
Self-citationCopy Number Variation and Schizophrenia
St Clair, D. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn147 · Cited by 100
Akula, N., Barb, J., Jiang, X., Wendland, J. R., Choi, K. H., Sen, S. K., Hou, L., Chen, D. T. W., Laje, G., Johnson, K., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.170 · Cited by 116
Sahoo, T., Theisen, A., Rosenfeld, J. A., Lamb, A. N., Ravnan, J. B., Schultz, R. A., Torchia, B. S., Neill, N., Casci, I., Bejjani, B. A., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182217a06 · Cited by 115
Inflammatory Molecular Signature Associated With Infectious Agents in Psychosis
Hayes, L. N., Severance, E. G., Leek, J. T., Gressitt, K. L., Rohleder, C., Coughlin, J. M., Leweke, F. M., Yolken, R. H., & Sawa, A. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu052 · Cited by 116
Crabtree, G. W., & Gogos, J. A. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00028 · Cited by 101
DNA fluorocode: A single molecule, optical map of DNA with nanometre resolution
Neely, R. K., Dedecker, P., Hotta, J., Urbanavičiūtė, G., Klimašauskas, S., & Hofkens, J. (2010) · Chemical Science · doi:10.1039/c0sc00277a · Cited by 115
Ingason, A., Kirov, G., Giegling, I., Hansen, T., Isles, A. R., Jakobsen, K. D., Kristinsson, K. T., le Roux, L., Gustafsson, O., Craddock, N., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09111660 · Cited by 114
“Aiming to discover novel pathogenic copy number variants, we performed a genome-wide copy number variant scan of 22 Danish schizophrenia patients with an early onset of disease (aged 10–15 years), under the premise that developmental forms of the disorder would be particularly enriched in this group (1).”
MethodKato, T., Abe, Y., Sotoyama, H., Kakita, A., Kominami, R., Hirokawa, S., Ozaki, M., Takahashi, H., & Nawa, H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.10 · Cited by 114
Copy Number Variation Disorders
Shaikh, T. H. (2017) · Current Genetic Medicine Reports · doi:10.1007/s40142-017-0129-2 · Cited by 115
Johnson, W., Penke, L., & Spinath, F. M. (2011) · European Journal of Personality · doi:10.1002/per.836 · Cited by 85
“Their involvement is increasingly suspected in major behavioural disorders such as schizophrenia and autism (Sebat et al., 2007; International Schizophrenia Consortium, 2008; Kumar et al., 2008; Morrow et al., 2008; Stefansson et al., 2008; Walsh et al., 2008; Xu et al., 2008).”
BackgroundDISC1 in Schizophrenia: Genetic Mouse Models and Human Genomic Imaging
Johnstone, M., Thomson, P. A., Hall, J., McIntosh, A. M., Lawrie, S. M., & Porteous, D. J. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq135 · Cited by 100
Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia
Koga, M., Ishiguro, H., Yazaki, S., Horiuchi, Y., Arai, M., Niizato, K., Iritani, S., Itokawa, M., Inada, T., Iwata, N., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp166 · Cited by 112
“Additionally, a disruption of the SMARCA2 gene in a patient with schizophrenia has been reported (42).”
BackgroundNeddens, J., Fish, K. N., Tricoire, L., Vullhorst, D., Shamir, A., Chung, W., Lewis, D. A., McBain, C. J., & Buonanno, A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.016 · Cited by 94
A brain atlas of synapse protein lifetime across the mouse lifespan
Bulovaite, E., Qiu, Z., Kratschke, M., Zgraj, A., Fricker, D. G., Tuck, E. J., Gokhale, R., Koniaris, B., Jami, S. A., Merino-Serrais, P., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.09.009 · Cited by 111
Mouse models of genetic effects on cognition: Relevance to schizophrenia
Papaleo, F., Lipska, B. K., & Weinberger, D. R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.025 · Cited by 111
Longitudinal sleep EEG trajectories indicate complex patterns of adolescent brain maturation
Feinberg, I., & Campbell, I. G. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00422.2012 · Cited by 105
“Observations on sleep EEG stimulated the “synaptic pruning” hypothesis of schizophrenia (13) and the complex patterns of postnatal sleep EEG maturation gave rise to the hypothesis that the 1% incidence of schizophrenia reflects a stochastic error in adolescent brain development rather than the frequency of a specific…”
BackgroundIdentification and functional characterization of rare SHANK2 variants in schizophrenia
Peykov, S., Berkel, S., Schoen, M., Weiss, K., Degenhardt, F., Strohmaier, J., Weiss, B., Proepper, C., Schratt, G., Nöthen, M. M., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.172 · Cited by 93
Recent genomic advances in schizophrenia
Doherty, J., O’Donovan, M., & Owen, M. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01773.x · Cited by 95
“1 Deletion Duplication NA NA (45, 47) Sz, MR, autism”
BackgroundResultHuman gene copy number spectra analysis in congenital heart malformations
Tomita-Mitchell, A., Mahnke, D. K., Struble, C. A., Tuffnell, M. E., Stamm, K. D., Hidestrand, M., Harris, S. E., Goetsch, M. A., Simpson, P. M., Bick, D. P., et al. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00013.2012 · Cited by 105
The individual and global impact of copy-number variants on complex human traits
Auwerx, C., Lepamets, M., Sadler, M. C., Patxot, M., Stojanov, M., Baud, D., Mägi, R., Esko, T., Metspalu, A., Milani, L. A., et al. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.02.010 · Cited by 110
The Genetics of Symptom-Based Phenotypes: Toward a Molecular Classification of Schizophrenia
DeRosse, P., Lencz, T., Burdick, K. E., Siris, S. G., Kane, J. M., & Malhotra, A. K. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn076 · Cited by 94
Detection and Characterization of Copy Number Variation in Autism Spectrum Disorder
Marshall, C. R., & Scherer, S. W. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-507-7_5 · Cited by 108
Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function
Balu, D. T., Carlson, G. C., Talbot, K., Kazi, H., Hill‐Smith, T. E., Easton, R. M., Birnbaum, M. J., & Lucki, I. (2012) · Hippocampus · doi:10.1002/hipo.20887 · Cited by 99
The genetic basis of thought disorder and language and communication disturbances in schizophrenia
Levy, D. L., Coleman, M. J., Sung, H., Ji, F., Matthysse, S., Mendell, N. R., & Titone, D. (2010) · Journal of Neurolinguistics · doi:10.1016/j.jneuroling.2009.08.003 · Cited by 99
“Even more intriguing, CNTNAP2 is a member of the Neurexin gene family and an excess of rare variants in neurexin1 has been associated with both schizophrenia (Kirov et al., 2008; Rujescu et al., 2008; Walsh et al., 2008) and autism (Kim et al.”
BackgroundImmune system gene dysregulation in autism and schizophrenia
Michel, M., Schmidt, M. J., & Mirnics, K. (2012) · Developmental Neurobiology · doi:10.1002/dneu.22044 · Cited by 107
“…et al., 2008; Need et al., 2009; Purcell et al., 2009; Shi et al., 2009; Stefansson et al., 2009; Yue et al., 2011) while others failed to replicate these findings (O’Donovan et al., 2008; Shifman et al., 2008; Walsh et al., 2008; Athanasiu et al., 2010; Ma et al., 2011; Yamada et al., 2011).”
GLT-1 transporter: An effective pharmacological target for various neurological disorders
Soni, N., Reddy, B. V. K., & Kumar, P. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.10.001 · Cited by 107
“…gene has also been found in schizophrenia patients (Walsh et al., 2008), while expression of a high-risk for schizophrenia allele of the GRM3 metabotropic glutamate receptor is associated with decreased EAAT-2 mRNA expression in human prefrontal cortex (Egan et al., 2004; Walsh et al., 2008).”
BackgroundInfluentialGreenwood, T. A., Lazzeroni, L. C., Maihofer, A. X., Swerdlow, N. R., Calkins, M. E., Freedman, R., Green, M. F., Light, G. A., Nievergelt, C. M., Nuechterlein, K. H., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.2850 · Cited by 107
Zamanpoor, M. (2019) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000245 · Cited by 107
“neuregulin and neurexin) related to synaptic development and functions (Walsh et al., 2008; Tam et al., 2009).”
BackgroundTromp, A., Mowry, B. J., & Giacomotto, J. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00944-8 · Cited by 107
“A subsequent report identified a 115 Kb deletion at the 3′ end disrupting NRXN1α and β in an affected twin pair (2/233 cases; 0/268 controls) [32].”
BackgroundNeural Mechanisms Underlying Repetitive Behaviors in Rodent Models of Autism Spectrum Disorders
Gandhi, T., & Lee, C. C. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592710 · Cited by 88
Karlsson, R., Tanaka, K., Heilig, M. A., & Holmes, A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.001 · Cited by 106
de Smith, A. J., Walters, R. G., Froguel, P., & Blakemore, A. I. F. (2008) · Cytogenetic and Genome Research · doi:10.1159/000184688 · Cited by 106
“These results are mirrored by another recent report of an association with rare variants affecting neurodevelopmental genes in cases of schizophrenia (Walsh et al., 2008).”
ResultSchizophrenia genetics: emerging themes for a complex disorder
Kavanagh, D. H., Tansey, K. E., O’Donovan, M. C., & Owen, M. J. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.148 · Cited by 105
Genetic insights and neurobiological implications from NRXN1 in neuropsychiatric disorders
Hu, Z., Xiao, X., Zhang, Z., & Li, M. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0438-9 · Cited by 106
Association study of 182 candidate genes in anorexia nervosa
Pinheiro, A. P., Bulik, C. M., Thornton, L. M., Sullivan, P. F., Root, T. L., Bloss, C. S., Berrettini, W. H., Schork, N. J., Kaye, W. H., Bergen, A. W., et al. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31082 · Cited by 92
“, 2009], analysis of copy number variations [Walsh et al., 2008], accommodation and consideration of epigenomic factors [Peedicayil, 2004] and sophisticated multilocus analyses.”
BackgroundAssessing the utility of intermediate phenotypes for genetic mapping of psychiatric disease
Flint, J., Timpson, N., & Munafò, M. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.08.007 · Cited by 92
Ku, C., Polychronakos, C., Tan, E., Naidoo, N., Pawitan, Y., Roukos, D. H., Mort, M. E., & Cooper, D. N. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.58 · Cited by 104
Evidence for X-Chromosomal Schizophrenia Associated with microRNA Alterations
Feng, J., Sun, G., Yan, J., Noltner, K., Li, W., Buzin, C. H., Longmate, J., Heston, L. L., Rossi, J., & Sommer, S. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006121 · Cited by 95
“The assessment of statistical significance is based on a single test of the collective effect of all microRNAs on the X-chromosome. This is similar to the strategy of Walsh et al. who tested the collective effect of individually rare copy number variants on the risk of schizophrenia”
ResultNeuregulin signaling, cortical circuitry development and schizophrenia
Rico, B., & Marín, Ó. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.12.010 · Cited by 105
Barnes, M. R., Huxley‐Jones, J., Maycox, P. R., Lennon, M., Thornber, A., Kelly, F., Bates, S., Taylor, A., Reid, J., Jones, N., et al. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22647 · Cited by 95
The Role of the Eukaryotic Translation Initiation Factor 4E (eIF4E) in Neuropsychiatric Disorders
Amorim, I. S., Lach, G., & Gkogkas, C. G. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00561 · Cited by 104
Genetic basis of autism: is there a way forward?
Eapen, V. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328345927e · Cited by 102
Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis
Need, A. C., Keefe, R. S. E., Ge, D., Grossman, I., Dickson, S., McEvoy, J. P., & Goldstein, D. B. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.264 · Cited by 102
Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications
Gaspar, P. A., Bustamante, M. L., Hernán Silva, I., & Aboitiz, F. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06325.x · Cited by 102
Schizophrenia genetics: advancing on two fronts
Owen, M. J., Williams, H. J., & O’Donovan, M. C. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.02.008 · Cited by 100
NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms
Snyder, M. A., & Gao, W. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.03.010 · Cited by 102
The genetics of childhood-onset schizophrenia: When madness strikes the prepubescent
Addington, A. M., & Rapoport, J. L. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0024-y · Cited by 90
Self-citationContemplating effects of genomic structural variation
Buchanan, J. A., & Scherer, S. W. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e318183f848 · Cited by 100
Tau's role in the developing brain: implications for intellectual disability
Sapir, T., Frotscher, M., Levy, T., Mandelkow, E.-M., & Reiner, O. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr603 · Cited by 89
Genomic imprinting in the development and evolution of psychotic spectrum conditions
Crespi, B. (2008) · Biological Reviews · doi:10.1111/j.1469-185x.2008.00050.x · Cited by 86
“MAGI2 alleles have been associated with schizophrenia risk by Buxbaum et al. (2008), and Walsh et al. (2008) reported an association between disruption of this gene via a duplication and a case of schizophrenia, in an analysis of copy number variants.”
BackgroundMosley, C. A., Acker, T. M., Hansen, K. B., Mullasseril, P., Andersen, K. T., Le, P., Vellano, K. M., Bräuner-Osborne, H., Liotta, D. C., & Traynelis, S. F. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100027p · Cited by 87
Metadata
- Authors
- Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Nord, A. S., Kusenda, M., Malhotra, D., Bhandari, A., Stray, S. M., Rippey, C. F., Roccanova, P., Makarov, V., Lakshmi, B., Findling, R. L., Sikich, L., Stromberg, T., Merriman, B., Gogtay, N., Butler, P., Eckstrand, K., Noory, L., Gochman, P., Long, R., Chen, Z., Davis, S., Baker, C., Eichler, E. E., Meltzer, P. S., Nelson, S. F., Singleton, A. B., Lee, M. K., Rapoport, J. L., King, M.-C., & Sebat, J.
- Affiliations
- National Institutes of Health (US)
- Department of Medicine, University of Washington, Seattle, WA 98195, USA.
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Walsh, Tom
- McClellan, Jon M.
- McCarthy, Shane E.
- Addington, Anjené M.
- ORCID
- Walsh, Tom
- McClellan, Jon M.
- Addington, Anjené M.
- Pierce, Sarah B.
- Nord, Alex S.
- Malhotra, Dheeraj
- Bhandari, Abhishek
- Lakshmi, B.
- Findling, Robert L.
- Sikich, Linmarie
- Merriman, Barry
- Eckstrand, Kristen
- Gochman, Peter
- Davis, Sean
- Eichler, Evan E.
- Meltzer, Paul S.
- Singleton, Andrew B.
- Lee, Ming K.
- King, Mary-Claire
- Sebat, Jonathan
- Venue
- Science
- Published
- 2008-04-25
- Volume
- 320
- Issue
- 5875
- Pages
- 539-543
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2161641617
- Cited by
- 1,800
- References
- 42
- Citations by year
- 2026: 6 · 2025: 21 · 2024: 43 · 2023: 28 · 2022: 42 · 2021: 49 · 2020: 49 · 2019: 60 · 2018: 60 · 2017: 67 · 2016: 70 · 2015: 99 · 2014: 108 · 2013: 127 · 2012: 177
- FWCI
- 150.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Institute of Mental Health (MH061355, MH061464, MH061528, U01MH061355, U01MH061528, U01MH061464)
- National Institute of Neurological Disorders and Stroke (U24NS052108, NS052108)
- National Center for Research Resources (RR025014, RR-000046, UL1RR025014, M01RR000046)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD043569, R01HD043569)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- schizophrenia, structural variants, microdeletion, microduplication, brain development, neuregulin signaling, glutamate signaling, childhood schizophrenia, genetic association, copy number variation
- MeSH terms
- Adolescent, Adult, Amino Acid Sequence, Brain, Child, Female, Humans, Male, Molecular Sequence Data, Mutation, Neurons, Schizophrenia, Signal Transduction, Genome, Human, Case-Control Studies, Gene Deletion, Age of Onset, Genetic Predisposition to Disease, Oligonucleotide Array Sequence Analysis, Gene Duplication, Polymorphism, Single Nucleotide, Excitatory Amino Acid Transporter 1, ErbB Receptors, Receptor, ErbB-4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.